These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34260945)

  • 1. Structure and dynamics of semaglutide- and taspoglutide-bound GLP-1R-Gs complexes.
    Zhang X; Belousoff MJ; Liang YL; Danev R; Sexton PM; Wootten D
    Cell Rep; 2021 Jul; 36(2):109374. PubMed ID: 34260945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM structure of the dual incretin receptor agonist, peptide-19, in complex with the glucagon-like peptide-1 receptor.
    Johnson RM; Zhang X; Piper SJ; Nettleton TJ; Vandekolk TH; Langmead CJ; Danev R; Sexton PM; Wootten D
    Biochem Biophys Res Commun; 2021 Nov; 578():84-90. PubMed ID: 34547628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryo-electron microscopy structure of the glucagon receptor with a dual-agonist peptide.
    Chang R; Zhang X; Qiao A; Dai A; Belousoff MJ; Tan Q; Shao L; Zhong L; Lin G; Liang YL; Ma L; Han S; Yang D; Danev R; Wang MW; Wootten D; Wu B; Sexton PM
    J Biol Chem; 2020 Jul; 295(28):9313-9325. PubMed ID: 32371397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The G Protein-First Mechanism for Activation of the Class B Glucagon-like Peptide 1 Receptor Coupled to N-Terminal Domain-Mediated Conformational Progression.
    Li B; Yang MY; Kim SK; Goddard WA
    J Am Chem Soc; 2024 Sep; 146(38):26251-26260. PubMed ID: 39266057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.
    Zhang Y; Sun B; Feng D; Hu H; Chu M; Qu Q; Tarrasch JT; Li S; Sun Kobilka T; Kobilka BK; Skiniotis G
    Nature; 2017 Jun; 546(7657):248-253. PubMed ID: 28538729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
    Gómez Santiago C; Paci E; Donnelly D
    Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
    Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
    J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors.
    Zhao F; Zhou Q; Cong Z; Hang K; Zou X; Zhang C; Chen Y; Dai A; Liang A; Ming Q; Wang M; Chen LN; Xu P; Chang R; Feng W; Xia T; Zhang Y; Wu B; Yang D; Zhao L; Xu HE; Wang MW
    Nat Commun; 2022 Feb; 13(1):1057. PubMed ID: 35217653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.
    Lau J; Bloch P; Schäffer L; Pettersson I; Spetzler J; Kofoed J; Madsen K; Knudsen LB; McGuire J; Steensgaard DB; Strauss HM; Gram DX; Knudsen SM; Nielsen FS; Thygesen P; Reedtz-Runge S; Kruse T
    J Med Chem; 2015 Sep; 58(18):7370-80. PubMed ID: 26308095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
    Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
    J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
    Wang H; Hu W; Liu D; Wüthrich K
    FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists.
    Zhang X; Belousoff MJ; Zhao P; Kooistra AJ; Truong TT; Ang SY; Underwood CR; Egebjerg T; Šenel P; Stewart GD; Liang YL; Glukhova A; Venugopal H; Christopoulos A; Furness SGB; Miller LJ; Reedtz-Runge S; Langmead CJ; Gloriam DE; Danev R; Sexton PM; Wootten D
    Mol Cell; 2020 Nov; 80(3):485-500.e7. PubMed ID: 33027691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24.
    Cong Z; Zhou Q; Li Y; Chen LN; Zhang ZC; Liang A; Liu Q; Wu X; Dai A; Xia T; Wu W; Zhang Y; Yang D; Wang MW
    Proc Natl Acad Sci U S A; 2022 May; 119(20):e2200155119. PubMed ID: 35561211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.
    Deganutti G; Liang YL; Zhang X; Khoshouei M; Clydesdale L; Belousoff MJ; Venugopal H; Truong TT; Glukhova A; Keller AN; Gregory KJ; Leach K; Christopoulos A; Danev R; Reynolds CA; Zhao P; Sexton PM; Wootten D
    Nat Commun; 2022 Jan; 13(1):92. PubMed ID: 35013280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor action in the vasculature.
    Almutairi M; Al Batran R; Ussher JR
    Peptides; 2019 Jan; 111():26-32. PubMed ID: 30227157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sgemaglutide in type 2 diabetes - is it the best glucagon-like peptide 1 receptor agonist (GLP-1R agonist)?
    Doggrell SA
    Expert Opin Drug Metab Toxicol; 2018 Mar; 14(3):371-377. PubMed ID: 29439603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
    Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
    J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into probe-dependent positive allosterism of the GLP-1 receptor.
    Bueno AB; Sun B; Willard FS; Feng D; Ho JD; Wainscott DB; Showalter AD; Vieth M; Chen Q; Stutsman C; Chau B; Ficorilli J; Agejas FJ; Cumming GR; Jiménez A; Rojo I; Kobilka TS; Kobilka BK; Sloop KW
    Nat Chem Biol; 2020 Oct; 16(10):1105-1110. PubMed ID: 32690941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and functional diversity among agonist-bound states of the GLP-1 receptor.
    Cary BP; Deganutti G; Zhao P; Truong TT; Piper SJ; Liu X; Belousoff MJ; Danev R; Sexton PM; Wootten D; Gellman SH
    Nat Chem Biol; 2022 Mar; 18(3):256-263. PubMed ID: 34937906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein.
    Kobayashi K; Shihoya W; Nishizawa T; Kadji FMN; Aoki J; Inoue A; Nureki O
    Nat Struct Mol Biol; 2020 Mar; 27(3):274-280. PubMed ID: 32157248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.